Medicine

Contact Us School of Medicine
Level 1
Trinity Biomedical Sciences Institute
Trinity College
152-160 Pearse Street
Dublin 2

View the contact page for more contact and location information

medadmin@tcd.ie
Dr. Sinead Smith

Dr. Sinead Smith

Ussher Assistant Professor, Clinical Medicine

Ussher Assistant Professor, Pharmacy

Publications and Further Research Outputs

  • Raftery T, Merrick M, Healy M, Mahmud N, O'Morain C, Smith S, McNamara D, O'Sullivan M., Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission., Digestive Diseases and Sciences, 60, (8), 2015, p2427 - 2435Journal Article, 2015, DOI
  • Haider RB, Brennan DE, Omorogbe J, Holleran G, Hall B, O'Morain C, Breslin N, O'Connor HJ, Smith SM*, McNamara D*., A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population., European Journal of Gastroenterology & Hepatology, 27, (11), 2015, p1265 - 1269Journal Article, 2015, DOI
  • Smith SM, An update on the treatment of Helicobacter pylori infection, EMJ Gastroenterology, 4, (1), 2015, p101 - 107Journal Article, 2015, URL , TARA - Full Text
  • Shang Y*, Smith S*, Hu X., Role of Notch signaling in regulating innate immunity and inflammation in health and disease, Protein & Cell, 7, (3), 2016, p159 - 174Journal Article, 2016, DOI , TARA - Full Text
  • Miller CH, Smith SM, Elguindy M, Zhang T, Xiang JZ, Hu X, Ivashkiv L, Zhao B., RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis, Journal of Immunology, 196, (12), 2016, p4977 - 4986Journal Article, 2016, DOI
  • Verma NK, Fazil MH, Ong ST, Chalasani ML, Low JH, Kottaiswamy A, P P, Kizhakeyil A, Kumar S, Panda AK, Freeley M, Smith SM, Boehm BO, Kelleher D., LFA-1/ICAM-1 Ligation in human T Cells promotes Th1 polarization through a GSK3β signaling-dependent Notch pathway. , Journal of Immunology, 197, (1), 2016, p108 - 118Journal Article, 2016, DOI
  • O'Morain C, Smith S, Heliocbacter pylori treatment failure: the rationale for alternative antibiotics, Digestion, 93, (4), 2016, p309 - 310Journal Article, 2016, DOI , TARA - Full Text
  • Smith SM, Freeley M, Moynagh P, Kelleher D, Differential modulation of Helicobacter pylori lipopolysaccharide-mediated TLR2 signaling by individual Pellino proteins., Helicobacter, 22, (1), 2017, pdoi: 10.1111/hel.12325Journal Article, 2017, DOI , TARA - Full Text
  • Non-invasive molecular tests for H. pylori in, Hospital Healthcare Europe 2016, London, Cogoro, 2016, pp197 - 199, [Brennan DE, McNamara D, Smith SM]Book Chapter, 2016, URL , TARA - Full Text
  • Smith SM, Strategies for the purification of membrane proteins, Methods in Molecular Biology, 1485, 2017, p389 - 400Journal Article, 2017, DOI , TARA - Full Text
  • Brennan DE, Omorogbe J, Hussey M, Tighe D, Holleran G, O'Morain C, Smith SM*, McNamara D*., Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples, World Journal of Gastroenterology, 7, (22), 2016, p9214 - 9221Journal Article, 2016, DOI , TARA - Full Text
  • Smith S,Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D, The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland., European Journal of Gastroenterology & Hepatology, 27, (5), 2017, p552 - 559Journal Article, 2017, DOI
  • Smith S,Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D, The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland., European Journal of Gastroenterology & Hepatology, 27, (5), 2017, p552 - 559Journal Article, 2017, DOI
  • Tighe D, Hall B, Jeyarajah SK, Smith S, Breslin N, Ryan B, McNamara D., One-Year Clinical Outcomes in an IBD Cohort Who Have Previously Had Anti-TNFa Trough and Antibody Levels Assessed., Inflammatory Bowel Diseases, 23, (7), 2017, p1154 - 1159Journal Article, 2017, DOI
  • Holleran G, Hussey M, Smith S, McNamara D., Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia., World Journal of Gastrointestinal Pathophysiology, 8, (3), 2017, p127 - 132Journal Article, 2017, DOI
  • Hussey M, Holleran G, Smith S, Sherlock M, McNamara D, The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease., Digestive Diseases and Sciences, 62, (12), 2017, p3385 - 3390Journal Article, 2017, DOI
  • Tighe D, Smith S, O'Connor A, Breslin N, Ryan B, McNamara D , Positive relationship between infliximab and adalimumab trough levels at completion of induction therapy with clinical response rates, at a tertiary referral center, JGH Open, 1, (1), 2017, p4 - 10Journal Article, 2017, DOI
  • Tighe D, Smith S, O'Connor A, Breslin N, Ryan B, McNamara D , Positive relationship between infliximab and adalimumab trough levels at completion of induction therapy with clinical response rates, at a tertiary referral center, JGH Open, 1, (1), 2017, p4 - 10Journal Article, 2017, DOI
  • Brennan D, Dowd C, O'Morain C, McNamara D, Smith SM, Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection?, World Journal of Gastroenterology, 24, (9), 2018, p971 - 981Journal Article, 2018, DOI , TARA - Full Text
  • Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, Engstrand L, Enroth H, Burette A, Megraud F, Varon C, Atherton JC, Smith S, Wilkinson TS, Hitchings MD, Falush D, Sheppard SK., A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk., BMC Biology, 16, (1), 2018, p84-Journal Article, 2018, DOI
  • Smith SM, O'Morain C, McNamara D, Helicobacter pylori resistance to current therapies., Current Opinion in Gastroenterology, 35, (1), 2019, p6 - 13Journal Article, 2019, DOI
  • Farzi N, Yadegar A, Sadeghi A, Aghdaei HA, Smith SM, Raymond J, Suzuki H, MR Zali., High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping, Journal of Clinical Medicine, 8, (11), 2019, pE2004-Journal Article, 2019, DOI , TARA - Full Text
  • Kang L, Zhang X, Ji L, Kou T, Smith S, Zhao B, Guo X, Pineda-Torra I, Wu L, Hu X., The colonic macrophage transcription factor RBP-J orchestrates intestinal immunity against bacterial pathogens, Journal of Experimental Medicine, 217, (4), 2020, pe20190762Journal Article, 2020, DOI , URL
  • Zhang X, Smith S, Wang X, Zhao B, Wu L, Hu X., Three paralogous clusters of miR-17~92 family microRNAs restrain IL-12-mediated immune defense, Cellular & Molecular Immunology, 18, (7), 2021, p1751 - 1760Journal Article, 2021, DOI
  • Douglas AR, Holleran G, Smith SM, McNamara D., Shared changes in angiogenic factors across gastrointestinal vascular conditions: a pilot study., World Journal of Gastrointestinal Pharmacology & Therapeutics., 11, (3), 2020, p40 - 47Journal Article, 2020
  • Nyssen OP, Bordin D, Tepes B, Pérez-Aisa Á, Vaira D, Caldas M, Bujanda L, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas L, Pérez-Lasala J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Axon ATR, Buzás G, Machado JC, Niv Y, Boyanova L, Goldis A, Lamy V, Tonkic A, Przytulski K, Beglinger C, Venerito M, Bytzer P, Capelle L, Milosavljević T, Milivojevic V, Veijola L, Molina-Infante J, Vologzhanina L, Fadeenko G, Ariño I, Fiorini G, Garre A, Garrido J, F Pérez C, Puig I, Heluwaert F, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators, European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21,533 patients, Gut, 70, (1), 2021, p40 - 54Journal Article, 2021, DOI
  • Zaslona Z, Flis E, Nulty C, Kearney J, Fitzgerald R, Douglas AR, McNamara D, Smith S, O'Neill LAJ, Creagh EM., Caspase-4: A Therapeutic Target for Peptic Ulcer Disease, Immunohorizons, 4, (10), 2021, p627 - 633Journal Article, 2021, DOI
  • Alavifard H, Mirzaei N, Yadegar A, Baghaei K, Smith SM, Sadeghi A, Zali MR, Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study, Current Microbiology, 78, 2021, p244 - 254Journal Article, 2021, DOI
  • Sinead Smith, Helicobacter pylori, Springer Nature , 2021Book, 2021, DOI , URL
  • Helicobacter pylori Virulence Factor Genotyping. in, Methods Mol Biol. 2283, 2021, pp93 - 106, [FitzGerald R, Sinha C, Yadegar A, Smith SM.]Book Chapter, 2021, DOI
  • Purification of Total RNA from Stomach Tissue Biopsies. in, Methods Mol Biol. 2283, 2021, pp51 - 59, [FitzGerald R, Devapal M, Hickey JJ, McNamara D, Kelleher D, Smith SM.]Book Chapter, 2021, DOI
  • Molecular Detection of Antibiotic-Resistant Helicobacter pylori. in, Methods Mol Biol. 2283, 2021, pp29 - 36, [Brennan D, O'Morain C, McNamara D, Smith SM.]Book Chapter, 2021, DOI
  • An Overview of Helicobacter pylori Infection. in, Methods Mol Biol. 2283, 2021, pp1 - 14, [FitzGerald R, Smith SM.]Book Chapter, 2021, DOI
  • Megraud F, Bruyndonckx R, Coenen S, Wittkop L, Huang TD, Hoebeke M, Bénéjat L, Lehours P, Goossens H, Glupczynski Y; European Helicobacter pylori Antimicrobial Susceptibility Testing Working Group., Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community, Gut, Apr 9, (gutjnl-2021-324032), 2021Journal Article, 2021, DOI
  • Nyssen OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, Kupcinskas J, Jonaitis L, Bujanda L, Lucendo A, Jurecic NB, Perez-Lasala J, Shvets O, Fadeenko G, Huguet JM, Kikec Z, Bordin D, Voynovan I, Leja M, Machado JC, Areia M, Fernandez-Salazar L, Rodrigo L, Alekseenko S, Barrio J, Ortuño J, Perona M, Vologzhanina L, Romero PM, Zaytsev O, Rokkas T, Georgopoulos S, Pellicano R, Buzas GM, Modolell I, Gomez Rodriguez BJ, Simsek I, Simsek C, Lafuente MR, Ilchishina T, Camarero JG, Dominguez-Cajal M, Ntouli V, Dekhnich NN, Phull P, Nuñez O, Lerang F, Venerito M, Heluwaert F, Tonkic A, Caldas M, Puig I, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators., Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)., American Journal of Gastroenterology, 116, (6), 2021, p1220 - 1229Journal Article, 2021, DOI
  • Bujanda L, Nyssen OP, Vaira D, Saracino IM, Fiorini G, Lerang F, Georgopoulos S, Tepes B, Heluwaert F, Gasbarrini A, Rokkas T, Bordin D, Smith S, Lamy V, Caldas M, Resina E, Muñoz R, Cosme A, Puig I, Megraud F, O'Morain C, Gisbert JP and on behalf of the Hp-EuReg Investigators., Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013-2020: Results of the European Registry on H. pylori Management (Hp-EuReg), Antibiotics, 10, (9), 2021, p1058-Journal Article, 2021, DOI
  • Nyssen OP, Vaira D, Aísa ÁP, Rodrigo L, Castro-Fernandez M, Jonaitis L, Tepes B, Vologzhanina L, Caldas M, Lanas A, Lucendo AJ, Bujanda L, Ortuño J, Barrio J, Huguet JM, Voynovan I, Lasala JP, Sarsenbaeva AS, Fernandez-Salazar L, Molina-Infante J, Jurecic NB, Areia M, Gasbarrini A, Kupčinskas J, Bordin D, Marcos-Pinto R, Lerand F, Leja M, Buzas GM, Niv Y, Rokkas T, Phull P, Smith S, Shvets O, Venerito M, Milivojevic V, Simsek I, Lamy V, Bytzer P, Boyanova L, Kunovský L, Beglinger C, Doulberis M, Marlicz W, Goldis A, Tonkić A, Capelle L, Puig I, Megraud F, Morain CO, Gisbert JP; Hp-EuReg Investigators., Empirical second-line therapy in 5,000 patients of the European Registry on Helicobacter pylori Management (Hp-EuReg), Clinical Gastroenterology and Hepatology, S1542-3565, (21), 2021, p01349-5Journal Article, 2021, DOI
  • Brennan D, O'Morain C, McNamara D, Smith SM, Combined antrum and corpus biopsy protocol improves Helicobacter pylori culture success, World Journal of Gastrointestinal Pathophysiology, 13, (1), 2022, p34 - 40Journal Article, 2022, DOI
  • Nyssen OP, Vaira D, Saracino IM, Fiorini G, Caldas M, Bujanda L, Pellicano R, Keco-Huerga A, Pabón-Carrasco M, Susanibar EO, Di Leo A, Losurdo G, Pérez-Aísa A, Gasbarini A, Boltin D, Smith S, Phull P, Rokkas T, Lamarque D, Cano-Català A, Puig I, Mégraud F, O'Morain C, Gisbert J.P. Gisbert, Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg), Journal of Clinical Medicine, 11, (6), 2022, p1658-Journal Article, 2022, DOI
  • Neves NCV, de Mello MP, Smith SM, Boylan F, Caliari MV, Castilho RO, Chemical Composition and In Vitro anti-Helicobacter pylori Activity of Campomanesia lineatifolia Ruiz & Pavón (Myrtaceae) Essential Oil, Plants, 11, (15), 2022, p1945-Journal Article, 2022, DOI
  • Nabavi-Rad A, Sadeghi A, Aghdaei HA, Yadegar A, Smith SM, Zali MR, The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management, Gut Microbes, 14, (1), 2022, p2108655-Journal Article, 2022, DOI
  • Burgos-Santamaría D, Nyssen OP, Gasbarrini A, Vaira D, Pérez-Aisa A, Rodrigo L, Pellicano R, Keco-Huerga A, Pabón-Carrasco M, Castro-Fernandez M, Boltin D, Barrio J, Phull P, Kupcinskas J, Jonaitis L, Ortiz-Polo I, Tepes B, Lucendo AJ, Huguet JM, Areia M, Jurecic NB, Denkovski M, Bujanda L, Román JR-S, Cuadrado-Lavín A, Gomez-Camarero J, Moreno MAG, Lanas A, Martinez-Dominguez SJ, Alfaro E, Marcos-Pinto R, Milivojevic V, Rokkas T, Leja M, Smith S, Buzás GM, Doulberis M, Venerito M, Lerang G, Bordin DS, Lamy V, Capelle LG, Marlicz W, Dobru D, Gridnyev O, Puig I, Mégraud F, O'Morain C, Gisbert JP On behalf of the Hp-EuReg Investigators, Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg), Gut, 2022Journal Article, 2022, DOI
  • Colm O'Morain, Sinead M Smith, Antimicrobial susceptibility testing for Helicobacter pylori comes of age, The Lancet Gastroenterology and Hepatology, 8, (7), 2023, p593 - 595Journal Article, 2023, DOI
  • García-Morales N, Pérez-Aísa Á, Fiorini G, Tepes B, Castro-Fernández M, Lucendo A, Voynovan I, Bujanda L, Garre A, Rodrigo L, Martínez Domínguez SJ, Denkovski M, Huguet Malavés JM, Jonaitis L, Bumane R, Zaytsev O, Mata Romero P, Barrio J, Fernández-Salazar L, Sarsenbaeva AS, Ortiz Polo I, Alekseenko S, Saracino IM, Vaira D, Keco-Huerga A, Bordin D, Gasbarrini A, Lerang F, Rokkas T, Kupcinskas J, Leja M, Babayeva G, Marcos Pinto R, Tonkic A, Smith S, Phull P, Buzas GM, Simsek H, Boltin D, Gridnyev O, Venerito M, Milivojevic V, Torà N, Cano-Català A, Moreira L, Nyssen OP, Mégraud F, O'Morain C, Gisbert JP, Puig I, On Behalf Of Hp-EuReg Investigators, Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management, Journal of Clinical Medicine, 12, (13), 2023, p4363-Journal Article, 2023, DOI
  • Strategies for the Purification of Membrane Proteins. in, editor(s)Loughran ST & Milne JJ , Protein Chromatography, Humana New York, NY, 2023, pp477 - 491, [Butler TJ, Smith SM.]Book Chapter, 2023
  • Nyssen OP, Pratesi P, Spínola MA, Jonaitis L , Pérez-Aísa A, Vaira D, Saracino IM, Pavoni M, Fiorini G, Tepes B, Bordin DS, Voynovan I, Lanas A, Martínez-Domínguez SJ, Alfaro E, Bujanda L, Pabón-Carrasco M, Hernández L , Gasbarrini A, Kupcinskas J, Lerang F, Smith SM, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Meštrovic A, Marlicz W, Milivojevic V, Simsek H, Kunovsky L, Papp V, Phull PS, Venerito M, Boyanova L, Boltin D, Niv Y, Matysiak-Budnik T, Doulberis M, Dobru D, Lamy V, Capelle LG, Trpchevska EN, Moreira L, Cano-Català A, Parra P, Mégraud F, O'Morain C, Ortega GJ, Gisbert J & on behalf of the Hp-EuReg Investigators, Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013-2022: Data from the European Registry on H. pylori Management (Hp-EuReg), Antibiotics, 12, (9), 2023, p1427-Journal Article, 2023, DOI
  • Yadegar A, Nabavi-Rad A, Smith SM, Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies, Frontiers in Cellular and Infection Microbiology, 13, 2023, p1296784-Journal Article, 2023, DOI
  • Jonaitis P, Nyssen OP, Saracino IM, Fiorini G, Vaira D, Pérez-Aísa Á, Tepes B, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Lucendo AJ, Lanas Á, Martínez-Domínguez SJ, Almajano EA, Rodrigo L, Vologzanina L, Brglez Jurecic N, Denkovski M, Bujanda L, Mahmudov U, Leja M, Lerang F, Babayeva G, Bordin DS, Gasbarrini A, Kupcinskas J, Gridnyev O, Rokkas T, Marcos-Pinto R, Phull PS, Smith SM, Tonkic A, Boltin D, Buzás GM, Šembera Š, Simsek H, Matysiak-Budnik T, Milivojevic V, Marlicz W, Venerito M, Boyanova L, Doulberis M, Capelle LG, Cano-Català A, Moreira L, Mégraud F, O'Morain C, Gisbert JP, Jonaitis L, Comparison of the management of Helicobacter pylori infection between the older and younger European populations, Scientific Reports, 13, (1), 2023, p17235-Journal Article, 2023, DOI
  • Butler TJ, Molloy S, McNamara D, Smith SM, Diagnosis of Helicobacter pylori infection, Microbiota In Health and Disease , (5), 2023, pe922-Journal Article, 2023, DOI
  • Molloy SD, Butler TJ, Merrigan I, Knight A, Parihar V, Van Der Merwe K, McNamara D, Smith SM, Evaluation of real-time PCR compared to culture for the detection of clarithromycin resistant Helicobacter pylori in the Irish healthcare setting, Microbiota in Health and Disease, 5, (e956), 2023Journal Article, 2023, DOI
  • Huguet JM, Ferrer-Barceló L, Suárez P, Barcelo-Cerda S, Sempere J, Saracino IM, Fiorini G, Vaira D, Pérez-Aísa Á, Jonaitis L, Tepes B, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Lucendo AJ, Lanas Á, Martínez-Domínguez SJ, Alfaro Almajano E, Rodrigo L, Vologzanina L, Bordin DS, Gasbarrini A, Babayeva G, Lerang F, Leja M, Kupcinskas J, Rokkas T, Marcos-Pinto R, Meštrovic A, Gridnyev O, Phull PS, Smith SM, Boltin D, Buzás GM, Kral J, Simsek H, Matysiak-Budnik T, Milivojevic V, Marlicz W, Venerito M, Boyanova L, Doulberis M, Capelle LG, Cano-Català A, Moreira L, Nyssen OP, Mégraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators., Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management, United European Gastroenterology Journal, 12, (6), 2024, p691 - 704Journal Article, 2024, DOI
  • Costigan C, O'Sullivan AM, O'Connell J, Sengupta S, Butler T, Molloy S, O'Hara FJ, Ryan B, Breslin N, O'Donnell S, O'Connor A, Smith S, McNamara D, Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort, World Journal of Clinical Cases, 12, (16), 2024, p2773 - 2779Journal Article, 2024, DOI
  • Smith SM, Boyle B, Buckley M, Costigan C, Doyle M, Farrell R, Ismail MS, Kevans D, Nugent S, O'Connor A, O'Morain C, Parihar V, Ryan C, McNamara D., The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland., European Journal of Gastroenterology & Hepatology, 36, (8), 2024, p1000 - 1009Journal Article, 2024, DOI
  • Martínez-Domínguez SJ, Nyssen OP, Lanas Á, Alfaro E, Jonaitis L, Mahmudov U, Voynovan I, Gülüstan B, Rodrigo L, Fiorini G, Perez-Aisa Á, Tejedor-Tejada J, Tepes B, Vologzanina L, Mammadov E, Lerang F, Oglu QFV, Bakulina NV, Abdulkhakov R, Tatiana I, Butler TJ, Sarsenbaeva AS, Bumane R, Lucendo AJ, Romano M, Bujanda L, Abdulkhakov SR, Zaytsev O, Pabón-Carrasco M, Keco-Huerga A, Denkovski M, Huguet JM, Perona M, Núñez Ó, Pavoni M, Fadieienko G, Alekseenko S, Smith SM, Hernández L, Kupcinskas J, Bordin DS, Leja M, Gasbarrini A, Gridnyev O, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators., Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg), Helicobacter, 29, (4), 2024, pe13111-Journal Article, 2024, DOI
  • Smith SM, Holleran G, O'Morain C, McNamara D., A local audit of eradication rates for first-line triple therapy for Helicobacter pylori and detection of multiresistant infection., Helicobacter, EHSG - XXVIth International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer, Madrid, Spain, Sep 12-14, 18, (S1), 2013, pp140Poster, 2013, DOI
  • Smith SM, Haider RB, Holleran G, Hall B, O'Connor H, Lawson A, O'Morain C, McNamara D., A molecular-genetics based approach for the detection of clarithromycin and fluoroquinolone resistant H. pylori. infection, EHSG - XXVIIth International Workshop on Helicobacter and Microbiota in Chronic Digestive Inflammation and Gastric Cancer, Rome, Italy, Sep 11-13, 19, (S1), 2014, pp152 - 152Poster, 2014, DOI
  • Tan A, Scortecci K, De Medeiros NMC, Kukula-Koch W, Butler TJ, Smith SM, Boylan F., Plukenetia volubilis Leaves as Source of anti-Helicobacter pylori agents., Frontiers in Pharmacology, 15, (1461447), 2024Journal Article, 2024, DOI
  • Smith S, Moran AP, Kelleher DP., Lipopolysaccharides from Helicobacter pylori NCTC11637 up-regulate IL-8 and VEGF via Toll-like receptor 2 in an epithelial cell system., Gastroenterology, Digestive Disease Week 2006, Los Angeles, USA, May 20 - 25, 130, (4), 2006, ppA526-Poster, 2006, DOI
  • Olmedo L, Calvet X, Gené E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Perez-Aisa Á, Lucendo AJ, Rodrigo L, Sarsenbaeva AS, Khlinov IB, Fadieienko G, Zaytsev O, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Jonaitis L, Núñez Ó, Pellicano R, Hernández L, Gridnyev O, Kupcinskas J, Gasbarrini A, Boltin D, Niv Y, Babayeva G, Marcos-Pinto R, Tepes B, Venerito M, Papp V, Lerang F, Leja M, Phull PS, Marlicz W, Doulberis M, Smith SM, Milivojevic V, Kunovsky L, Mestrovic A, Matysiak-Budnik T, Simsek H, Cano-Català A, Puig I, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg investigators., Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg), Gut, 2024Journal Article, 2024, DOI
  • Neves NCV, de Mello MP, Smith SM, Boylan F, Caliari MV, Castilho RO., Bioactive properties of Campomanesia lineatifolia: correlation between anti-Helicobacter pylori activity, antioxidant potential and chemical composition, Frontiers in Pharmacology, 13, (22), 2024, p3117-Journal Article, 2024, DOI
  • Costigan C, Comerford M, Whitmarsh R, Van der Merwe K, Madders G, O'Connell J, Butler T, Molloy S, O'Hara F, Ryan B, Breslin N, O'Donnell S, O'Connor A, Smith S, Ismail S, Parihar V, McNamara D., Bismuth quadruple therapy with doxycycline is an effective first-line therapy in an Irish cohort for Helicobacter pylori, Irish Society of Gastroenterology Winter Meeting 2024, Killiney, Ireland, Nov 21-22, 2024Oral Presentation, 2024
  • Malizia AP, Keating DT, Smith SM, Walls D, Doran PP, Egan JJ., Alveolar Epithelial Cell Injury with Epstein Barr Virus Upregulates TGF{beta}1 Expression., American Journal of Physiology-Lung Cellular and Molecular Physiology, 295, (3), 2008, pL451 - L460Journal Article, 2008, URL
  • Keating DT, Sadlier DM, Patricelli A, Smith SM, Walls D, Egan JJ, Doran PP., Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells., Respiratory Research, 1, (7), 2006, p114 - 129Journal Article, 2006, URL , TARA - Full Text
  • Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gélinas C, Walls D., Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway., Journal of Virology, 80, (16), 2006, p8133 - 8144Journal Article, 2006, URL
  • D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gélinas C, Walls D., Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor., Journal of Virology, 78, (4), 2004, p1800 - 1816Journal Article, 2004, URL
  • Mullaney E, Brown PA, Smith SM, Botting CH, Yamaoka YY, Terres AM, Kelleher DP, Windle HJ, Proteomic and functional characterization of the outer membrane vesicles from the gastric pathogen Helicobacter pylori, Proteomics Clinical Applications, 3, 2009, p785 - 796Journal Article, 2009
  • Duggan SP, Behan FM, Kirca M, Smith S, Reynolds JV, Long A, Kelleher D, An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid responsive gene, down regulated in Barrett's oesophagus, which regulates NF-kB activation and cytokine levels., Carcinogenesis, 5, 2010, p936 - 945Journal Article, 2010, DOI , URL
  • Strategies for the purification of membrane proteins in, editor(s)Dermot Walls & Sinead Loughran , Methods in Molecular Biology, Springer, 2011, pp485 - 496, [Smith SM]Book Chapter, 2011, URL , TARA - Full Text
  • An overview of microRNA methods: expression profiling and target identification in, editor(s)Virginia Espina & Lance Liotta , Methods in Molecular Biology, Springer, 2012, pp119 - 138, [Smith SM, Murray DW.]Book Chapter, 2012, URL
  • Smith SM, Moran AP, Duggan S, Ahmed SE, Mohamed AS, Windle HJ, O'Neill L, and Kelleher D., Tribbles 3: A Novel Regulator of TLR2-Mediated Signaling in Response to Helicobacter pylori Lipopolysaccharide , Journal of Immunology, 186, (4), 2011, p2462 - 2471Journal Article, 2011, URL
  • Loughran ST, Campion EM, D'Souza BN, Smith SM, Vrzalikova K, Wen K, Murray PG, Walls D., Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells., International Journal of Cancer, 129, (12), 2011, p2787 - 2796Journal Article, 2011
  • Ryan A, Lynch M, Smith SM, Amu S, Nel HJ, McCoy CE, Dowling JK, Draper E, O'Reilly V, McCarthy C, O'Brien J, Ní Eidhin D, O'Connell MJ, Keogh B, Morton CO, Rogers TR, Fallon PG, O'Neill LA, Kelleher D, Loscher CE., A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins., PLOS: Pathogens, 7, (6), 2011, pe1002076-Journal Article, 2011, URL , TARA - Full Text
  • Xu H*, Zhu J*, Smith S*, Foldi J, Zhao B, Chung AY, Outtz H, Kitajewski J, Shi C, Weber S, Saftig P, Li Y, Ozato K, Blobel CP, Ivashkiv LB, Hu X., Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization., Nature Immunology, 13, (7), 2012, p642 - 650Journal Article, 2012, URL , TARA - Full Text
  • Campion EM, Hakimjavadi R, Loughran ST, Phelan S, Smith SM, D'Souza BN, Tierney RJ, Bell AI, Cahill PA, Walls D, Repression of the pro-apoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonises TGF-β1-induced B-cell apoptosis, Journal of Virology, 88, (9), 2014, p5001 - 5013Journal Article, 2014
  • microRNA Profiling: An Overview of Current Technologies and Applications in, editor(s)García-Cañas V, Cifuentes A, Simó C. , Applications of Advanced Omics Technologies: From Genes to Metabolites, Elsevier, 2014, pp23 - 46, [Smith SM, Murray DW]Book Chapter, 2014, TARA - Full Text
  • Smith SM, Haider RB, O'Connor H, McNamara D, O'Morain C., Practical treatment of Helicobacter pylori: a balanced view in changing times., European Journal of Gastroenterology & Hepatology, 26, (8), 2014, p819 - 825Journal Article, 2014, DOI
  • Smith SM, O'Morain C, McNamara D, Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance, World Journal of Gastroenterology, 20, (29), 2014, p9912 - 9921Journal Article, 2014, DOI
  • Smith, SM, Role of Toll-like receptors in Helicobacter pylori infection and immunity., World Journal of Gastrointestinal Pathophysiology, 5, (3), 2014, p133 - 146Journal Article, 2014
  • Hall BJ, Holleran GE, Smith SM, Mahmud N, McNamara DA., A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy., European Journal of Gastroenterology & Hepatology, 26, (11), 2014, p1253 - 1259Journal Article, 2014, DOI
  • Hall B, Holleran G, Chin JL, Smith S, Ryan B, Mahmud N, McNamara D., A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy., Journal of Crohn's & Colitis, S1873-9946, (14), 2014, p286-4-Journal Article, 2014, DOI
  • Holleran G, Hall B, O'Regan M, Smith S, McNamara D., Expression of Angiogenic Factors in Patients With Sporadic Small Bowel Angiodysplasia., Journal of Clinical Gastroenterology, 49, (10), 2015, p831 - 836Journal Article, 2015, DOI

Recognition

  • Member of the Irish Society for Gastroenterology present
  • Member of the Irish Society for Immunology present
  • Coordinator of the Irish Helicobacter pylori Working Group 2015-present
  • Frontiers in Cellular & Infection Microbiology Topic Editor 2022-2023
  • National Coordinator of the European Registry on Helicobacter pylori management (Hp-EuReg) 2020-present
  • National Coordinator of the European Helicobacter pylori Antimicrobial Susceptibility Testing Working Group 2018-present
  • Frontiers in Immunology Editorial Board Member 2020-present
  • Frontiers in Gastroenterology Editorial Board Member 2021-present
  • World Journal of Gastroenterology Editorial Board Member 2014-present
  • Frontiers in Immunology Editorial Board Member 2020-present
  • Frontiers in Immunology Editorial Board Member 2020-present
  • Frontiers in Immunology Editorial Board Member 2020-present